Literature DB >> 1463865

Factors affecting protein composition of breast secretions from nonlactating women.

F Vizoso1, L M Sánchez, I Díez-Itza, M Luz Lamelas, C López-Otín.   

Abstract

Breast secretions can be classified into two types according to their major protein components. Type I fluids contain Zn-alpha 2-glycoprotein, apolipoprotein D, and gross cystic disease fluid protein-15, while Type II fluids are characterized by the presence of lactoferrin, lysozyme, and alpha-lactalbumin. In this study, the polypeptide composition of breast secretions from 719 nonlactating women was evaluated by using polyacrylamide gel electrophoresis. The required amount for the analysis (1 microliter) was obtained from 50% of control women and from 75% of women with mammary disease. There were more secretors in premenopausal than in postmenopausal women, as well as in parous than in nulliparous women. Evaluation of factors affecting protein composition of breast secretions revealed that Type II fluids were found in the majority of women who had given birth in the last four years and in a high proportion of oral contraceptive users. After excluding both of these groups, Type II fluids were detected in 47% of patients with breast cancer, but only in 8% of control women and in 16% of women with benign breast diseases. Taken together, these results suggest that protein analysis of breast secretions could be an useful tool for the study of breast pathologies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463865     DOI: 10.1007/bf01833522

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  31 in total

1.  Cytologic evaluation of breast fluid in the detection of breast disease.

Authors:  O W Sartorius; H S Smith; P Morris; D Benedict; L Friesen
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

2.  Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.

Authors:  L M Sánchez; F Vizoso; I Díez-Itza; C López-Otín
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

3.  Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk.

Authors:  N L Petrakis; M R Wrensch; V L Ernster; R Miike; J Murai; N Simberg; P K Siiteri
Journal:  Int J Cancer       Date:  1987-11-15       Impact factor: 7.396

4.  Testosterone in breast fluid.

Authors:  P Hill; L Garbaczewski; E L Wynder
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

5.  Prognostic significance of atypical epithelial hyperplasia in nipple aspirates of breast fluid.

Authors:  N L Petrakis; M R Wrensch; V L Ernster; R Miike; E B King; W H Goodson
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

6.  Mutagenic activity in nipple aspirates of human breast fluid.

Authors:  N L Petrakis; C A Maack; R E Lee; M Lyon
Journal:  Cancer Res       Date:  1980-01       Impact factor: 12.701

7.  A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease.

Authors:  D P Rose; B Berke; L A Cohen; H Lahti
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

8.  Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease.

Authors:  M R Wrensch; N L Petrakis; L D Gruenke; R Miike; V L Ernster; E B King; W W Hauck; J C Craig; W H Goodson
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

9.  Prolactin and murine mammary tumorigenesis: a review.

Authors:  C W Welsch; H Nagasawa
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

10.  Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.

Authors:  W R Miller; V Humeniuk; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

View more
  3 in total

1.  A strong association between body fat mass and protein profiles in nipple aspirate fluid of healthy premenopausal non-lactating women.

Authors:  Yafei Huang; Manubai Nagamani; Karl E Anderson; Alexander Kurosky; Anthony M Haag; James J Grady; Lee-Jane W Lu
Journal:  Breast Cancer Res Treat       Date:  2006-09-27       Impact factor: 4.872

2.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Expression and prognostic significance of lysozyme in male breast cancer.

Authors:  Carlos Serra; Francisco Vizoso; Lorena Alonso; Juan C Rodríguez; Luis O González; María Fernández; María L Lamelas; Luis M Sánchez; José L García-Muñiz; Aniceto Baltasar; Justo Medrano
Journal:  Breast Cancer Res       Date:  2002-08-27       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.